Patent 7736895 was granted and assigned to Kyowa Hakko Kirin on June, 2010 by the United States Patent and Trademark Office.
The invention provides methods for altering the expression profile of a cell to convert the cell from one cell type to a desired cell type. These reprogrammed cells may be used in a variety of medical applications for treating a mammal in need of a particular cell type.